Intriguingly, there was no signal of strong HER2 activation in pre-treatment HER2-positive gastric cancer samples, despite the increased HER2 protein level in this group (Fig. S2c), indicating the complexity of the relationship between protein abundance and functionality. Here, ERBB2 is linked to gastric cancer.